The Determinants of Drug Prescribing by Hospital Doctor-Using Drug Innovativeness as Moderators

碩士 === 長庚大學 === 工商管理學系 === 99 === The purpose of this study is to investigate the determinants of hospital doctors’ new drugs prescribing behavior. This study focuses on the social determinants of physicians’ new drug adoption behavior. This studies recognizing the importance of opinion leader and c...

Full description

Bibliographic Details
Main Authors: Kuan An Jan, 任冠安
Other Authors: S. J. Lin
Format: Others
Published: 2009
Online Access:http://ndltd.ncl.edu.tw/handle/21334840955281680895
id ndltd-TW-097CGU05457051
record_format oai_dc
spelling ndltd-TW-097CGU054570512015-10-13T12:04:56Z http://ndltd.ncl.edu.tw/handle/21334840955281680895 The Determinants of Drug Prescribing by Hospital Doctor-Using Drug Innovativeness as Moderators 醫師新藥採用行為之決定因素-以藥品新穎性為干擾變項 Kuan An Jan 任冠安 碩士 長庚大學 工商管理學系 99 The purpose of this study is to investigate the determinants of hospital doctors’ new drugs prescribing behavior. This study focuses on the social determinants of physicians’ new drug adoption behavior. This studies recognizing the importance of opinion leader and colleagues in the new drug diffusion process with analyzing the prescribing behavior of new drug adopted by colleagues and consultants. Furthermore, the novelty of the drugs is considered as moderating effect. The main argument of this research is that when a drug is in high novelty (i.e., drugs belong to the category of New Molecular Entity) physicians will be more rely on social cues to adopt this new drug. Specifically, physicians usually lack of knowledge and personal experience on a new drug, such as its curative effect, side effect or appropriate dosage. Under such an uncertain decision context and the presumed bounded rationality, physicians will rely on some simplified rule or social signals in making decisions. Contrastingly, prescribing less novel new drugs such as those in the category of New Combination of Two or More Drugs, social signals are less used. Academically, new product adoption or technology diffusion has attracted many scholars. This study will contribute to this research stream by apply the behavioral theory in the context of personal adoption decisions. To our best knowledge, all of the published studies regarding physicians’ prescription decision are conducted by interviews or case studies. The lack of large-sample empirical evidence in pior literature leads to a unclear generalizability of their findings. Thus, our study can bridge the empirical gap by providing systematic empirical evidence in use of National Health Insurance Research Database. S. J. Lin 林舒柔 2009 學位論文 ; thesis 99
collection NDLTD
format Others
sources NDLTD
description 碩士 === 長庚大學 === 工商管理學系 === 99 === The purpose of this study is to investigate the determinants of hospital doctors’ new drugs prescribing behavior. This study focuses on the social determinants of physicians’ new drug adoption behavior. This studies recognizing the importance of opinion leader and colleagues in the new drug diffusion process with analyzing the prescribing behavior of new drug adopted by colleagues and consultants. Furthermore, the novelty of the drugs is considered as moderating effect. The main argument of this research is that when a drug is in high novelty (i.e., drugs belong to the category of New Molecular Entity) physicians will be more rely on social cues to adopt this new drug. Specifically, physicians usually lack of knowledge and personal experience on a new drug, such as its curative effect, side effect or appropriate dosage. Under such an uncertain decision context and the presumed bounded rationality, physicians will rely on some simplified rule or social signals in making decisions. Contrastingly, prescribing less novel new drugs such as those in the category of New Combination of Two or More Drugs, social signals are less used. Academically, new product adoption or technology diffusion has attracted many scholars. This study will contribute to this research stream by apply the behavioral theory in the context of personal adoption decisions. To our best knowledge, all of the published studies regarding physicians’ prescription decision are conducted by interviews or case studies. The lack of large-sample empirical evidence in pior literature leads to a unclear generalizability of their findings. Thus, our study can bridge the empirical gap by providing systematic empirical evidence in use of National Health Insurance Research Database.
author2 S. J. Lin
author_facet S. J. Lin
Kuan An Jan
任冠安
author Kuan An Jan
任冠安
spellingShingle Kuan An Jan
任冠安
The Determinants of Drug Prescribing by Hospital Doctor-Using Drug Innovativeness as Moderators
author_sort Kuan An Jan
title The Determinants of Drug Prescribing by Hospital Doctor-Using Drug Innovativeness as Moderators
title_short The Determinants of Drug Prescribing by Hospital Doctor-Using Drug Innovativeness as Moderators
title_full The Determinants of Drug Prescribing by Hospital Doctor-Using Drug Innovativeness as Moderators
title_fullStr The Determinants of Drug Prescribing by Hospital Doctor-Using Drug Innovativeness as Moderators
title_full_unstemmed The Determinants of Drug Prescribing by Hospital Doctor-Using Drug Innovativeness as Moderators
title_sort determinants of drug prescribing by hospital doctor-using drug innovativeness as moderators
publishDate 2009
url http://ndltd.ncl.edu.tw/handle/21334840955281680895
work_keys_str_mv AT kuananjan thedeterminantsofdrugprescribingbyhospitaldoctorusingdruginnovativenessasmoderators
AT rènguānān thedeterminantsofdrugprescribingbyhospitaldoctorusingdruginnovativenessasmoderators
AT kuananjan yīshīxīnyàocǎiyòngxíngwèizhījuédìngyīnsùyǐyàopǐnxīnyǐngxìngwèigànrǎobiànxiàng
AT rènguānān yīshīxīnyàocǎiyòngxíngwèizhījuédìngyīnsùyǐyàopǐnxīnyǐngxìngwèigànrǎobiànxiàng
AT kuananjan determinantsofdrugprescribingbyhospitaldoctorusingdruginnovativenessasmoderators
AT rènguānān determinantsofdrugprescribingbyhospitaldoctorusingdruginnovativenessasmoderators
_version_ 1716852520334131200